Familial predisposition to breast cancer in a British population: implications for prevention

被引:46
作者
Pharoah, PDP
Lipscombe, JM
Redman, KL
Day, NE
Easton, DF
Ponder, BAJ
机构
[1] Univ Cambridge, Strangeways Res Labs, Dept Oncol, CRC Human Canc Genet Grp, Cambridge CB1 8RN, England
[2] Univ Cambridge, Strangeways Res Labs, Dept Community Med, CRC Genet Epidemiol Grp, Cambridge CB1 8RN, England
关键词
breast cancer; risk; family history; prevention;
D O I
10.1016/S0959-8049(00)00023-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aims of this study were to estimate the familial relative risk of breast cancer according to the age of the at risk individual and the age at which the relative was affected, and to estimate the proportion of the general population in several breast cancer risk categories because of a family history and. thus estimate the potential to reduce the overall breast cancer burden using interventions targeted at women at increased risk because of family history. Familial relative risks were computed by comparing breast cancer incidence in relatives of 2809 breast cancer cases From a population based case series with that expected from general population incidence rates. The proportion of the general population in different categories of risk according to family history was estimated from the relative risk of breast cancer for that category and the proportion of cases in that category. 389 (13.8%) cases had at least 1 first degree relative with boast cancer, The relative risk of breast cancer in sisters of index cases was 1.90 (95% confidence interval (CI) 1.53-2.36) and that in mothers 1.73 (1.52-1.97). The risk to mothers of cases diagnosed under 50 years of age tended to decrease in older mothers, but no age effect was seen for mothers of cases diagnosed greater than or equal to 50 years of age. There was no evidence that relative risk to sisters declined with age. For women with 2 affected first degree relatives the relative risk was 2.85 (2.12-3.76). From these data, we estimate that in the general population 6.8% of women under the age of 50 years and 9.7% of women aged 50-65 years have at least 1 first degree relative affected with breast cancer. Two per cent of women under 50 years have a family history which confers an increased risk of at least 2.5-fold. An intervention targeted at this group that reduced breast cancer morbidity by 20% would reduce the total burden of breast cancer in this age group by 1.1% at most. A family history of breast cancer is quite common in the general population, but preventive interventions targeted at women at high risk of breast cancer because of Family history will have limited impact on breast cancer morbidity as a whole. (C) 2000 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:773 / 779
页数:7
相关论文
共 23 条
[1]  
ADAMI HO, 1981, CANCER, V48, P1688, DOI 10.1002/1097-0142(19811001)48:7<1688::AID-CNCR2820480736>3.0.CO
[2]  
2-W
[3]   VARIATIONS IN THE RISK OF BREAST-CANCER ASSOCIATED WITH A FAMILY HISTORY OF BREAST-CANCER ACCORDING TO AGE AT ONSET AND REPRODUCTIVE FACTORS [J].
ANDRIEU, N ;
CLAVEL, F ;
AUQUIER, A ;
LE, MG ;
GAIRARD, B ;
PIANA, L ;
BREMOND, A ;
LANSAC, J ;
FLAMANT, R ;
RENAUD, R .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (09) :973-980
[4]  
BAIN C, 1980, AM J EPIDEMIOL, V111, P301, DOI 10.1093/oxfordjournals.aje.a112901
[5]  
BRSLOW NE, 1980, STAT METHODS CANC RE, V2
[6]   FAMILY HISTORY, AGE, AND RISK OF BREAST-CANCER - PROSPECTIVE DATA FROM THE NURSES HEALTH STUDY [J].
COLDITZ, GA ;
WILLETT, WC ;
HUNTER, DJ ;
STAMPFER, MJ ;
MANSON, JE ;
HENNEKENS, CH ;
ROSNER, BA ;
SPEIZER, FE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (03) :338-343
[7]   The effect of raloxifene on risk of breast cancer in postmenopausal women - Results from the MORE randomized trial [J].
Cummings, SR ;
Eckert, S ;
Krueger, KA ;
Grady, D ;
Powles, TJ ;
Cauley, JA ;
Norton, L ;
Nickelsen, T ;
Bjarnason, NH ;
Morrow, M ;
Lippman, ME ;
Black, D ;
Glusman, JE ;
Costa, A ;
Jordan, VC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (23) :2189-2197
[8]  
*DEP HLTH, 1993, HLTH NAT KEY AR HDB
[9]  
Feig SA, 1997, CANCER-AM CANCER SOC, V80, P2035, DOI 10.1002/(SICI)1097-0142(19971201)80:11<2035::AID-CNCR1>3.0.CO
[10]  
2-W